Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology
Financial Post ·
Licensable perturbation dataset to include transcriptomes and proteomic secretomes for understanding the human immune response SEATTLE & MONTREAL — Parse Biosciences, the leading provider of scalable and accessible single-cell sequencing and a QIAGEN company, and Nomic Bio, a leader in high throughput proteomic profiling, today announced their partnership to generate Cascade, a 100 Million cell […]
SEATTLE & MONTREAL -- Parse Biosciences , the leading provider of scalable and accessible single-cell sequencing and a QIAGEN company, and Nomic Bio , a leader in high throughput proteomic profiling, today announced their partnership to generate Cascade, a 100 Million cell foundational dataset to understand the human immune response. The dataset's scale and depth will give pharma partners cellular- and protein-level insight into immune biology, accelerating their ability to identify and validate new drug targets. Read More